Bottom line
RYOAX vs FBTAX: the short answer
RYOAX (Biotechnology Fund) and FBTAX (Fidelity Advisor Biotechnology Fund) are both mutual funds.
FBTAX is cheaper at 0.94% vs 1.63% — a difference of $69 a year per $10,000 invested.
Over five years, FBTAX returned +6.4% a year vs +3.8% for RYOAX (reporting dates differ).
Updated Nov 19, 2026
RYOAX vs FBTAX side by side
| RYOAX | FBTAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Guggenheim | Fidelity |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 1.63% | 0.94% |
| Annual cost per $10k | $163 | $94 |
| 10-yr cost on $10k (prospectus) | $1,983 | $1,663 |
| Max front load | — | — |
| 12b-1 fee | 0.25% | 0.25% |
| 1-yr return | +30.4% | +31.5% |
| 5-yr return (annualized) | +3.8% | +6.4% |
| 10-yr return (annualized) | +5.6% | +7.7% |
| Best quarter | — | +30.3% |
| Worst quarter | — | −27.8% |
| Net assets (fund) | $136.8M | $2.2B |
| Number of holdings | 74 | 129 |
| Portfolio turnover | 75% | 54% |
| Returns as of | Dec 31, 2025 | Sep 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of RYOAX's top 25 holdings also appear in FBTAX's top 25.
| Holding | RYOAX | FBTAX |
|---|---|---|
| Abbvie Inc | 8.17% | 14.71% |
| Amgen Inc | 5.05% | 2.37% |
| Gilead Sciences Inc | 4.49% | 5.70% |
| Vertex Pharmaceuticals Inc | 4.32% | 1.39% |
| Revolution Medicines Inc | 2.48% | 3.00% |
| Alnylam Pharmaceuticals Inc | 2.36% | 3.62% |
| Moderna Inc | 2.15% | 1.60% |
| Biogen Inc | 2.13% | 2.71% |
| Natera Inc | 2.12% | 1.43% |
| Insmed Inc | 1.79% | 3.05% |
| Argenx Se | 1.48% | 3.00% |
Source: SEC Form N-PORT
RYOAX top 10
- Abbvie Inc — 8.17%
- Amgen Inc — 5.05%
- Gilead Sciences Inc — 4.49%
- Vertex Pharmaceuticals Inc — 4.32%
- Regeneron Pharmaceuticals Inc — 2.93%
- Revolution Medicines Inc — 2.48%
- Alnylam Pharmaceuticals Inc — 2.36%
- Beone Medicines Ltd — 2.17%
- Moderna Inc — 2.15%
- Biogen Inc — 2.13%
FBTAX top 10
- Abbvie Inc — 14.71%
- Gilead Sciences Inc — 5.70%
- Spyre Therapeutics Inc — 3.83%
- Alnylam Pharmaceuticals Inc — 3.62%
- Dianthus Therapeutics Inc — 3.55%
- Cogent Biosciences Inc — 3.25%
- Oruka Therapeutics Inc — 3.24%
- Insmed Inc — 3.05%
- Revolution Medicines Inc — 3.00%
- Argenx Se — 3.00%
FAQ
What is the difference between RYOAX and FBTAX?
RYOAX (Biotechnology Fund) and FBTAX (Fidelity Advisor Biotechnology Fund) are both mutual funds. FBTAX is cheaper at 0.94% vs 1.63% — a difference of $69 a year per $10,000 invested.
Which is cheaper, RYOAX or FBTAX?
FBTAX has the lower expense ratio (0.94%).
Should I own both RYOAX and FBTAX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.